Relapsing fever natural history, complications and prognosis

Revision as of 15:48, 3 December 2012 by Prashanthsaddala (talk | contribs)
Jump to navigation Jump to search

Relapsing fever Microchapters

Home

Patient Information

Overview

Historical Perspective

Classification

Pathophysiology

Causes

Differentiating Relapsing fever from other Diseases

Epidemiology and Demographics

Risk Factors

Natural History, Complications and Prognosis

Diagnosis

History and Symptoms

Physical Examination

Laboratory Findings

Imaging Findings

Other Diagnostic Studies

Treatment

Medical Therapy

Prevention

Cost-Effectiveness of Therapy

Future or Investigational Therapies

Case Studies

Case #1

Relapsing fever natural history, complications and prognosis On the Web

Most recent articles

Most cited articles

Review articles

CME Programs

Powerpoint slides

Images

American Roentgen Ray Society Images of Relapsing fever natural history, complications and prognosis

All Images
X-rays
Echo & Ultrasound
CT Images
MRI

Ongoing Trials at Clinical Trials.gov

US National Guidelines Clearinghouse

NICE Guidance

FDA on Relapsing fever natural history, complications and prognosis

CDC on Relapsing fever natural history, complications and prognosis

Relapsing fever natural history, complications and prognosis in the news

Blogs on Relapsing fever natural history, complications and prognosis

Directions to Hospitals Treating Relapsing fever

Risk calculators and risk factors for Relapsing fever natural history, complications and prognosis

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]

Complications

  • Coma
  • Facial droop
  • Liver dysfunction
  • Meningitis
  • Myocarditis -- may lead to arrhythmias
  • Pneumonia
  • Seizures
  • Shock related to taking antibiotics (Jarisch - Herxheimer's reaction, in which the rapid death of very large numbers of Borrelia organisms induces shock)
  • Weakness
  • Widespread bleeding

Prognosis

The death rate for untreated LBRF ranges from 10 - 70%. In TBRF, it is 4 -10%. With early treatment, the death rate is reduced. Those who have developed coma, myocarditis, liver problems, or pneumonia are more likely to die.

References